Videos
Press Releases
Latest Newsletters
News
29 Feb 2024
EORTC: Advancing research and treatment for rare cancers
22 Feb 2024
EORTC Fellowship Programme: celebrating more than 20 years of impactful collaboration
9 Feb 2024
Appointment of Malte Peters as EORTC Strategic Alliance Officer
7 Feb 2024
Unique series of workshops in partnership with the European Medicines Agency (EMA)
14 Dec 2023
EORTC launches a prominent clinical trial in older patients with locally advanced (LA) HNSCC (Head and Neck Squamous Cell Carcinoma)
6 Dec 2023
Seven IMMUcan abstracts selected for ESMO Immuno-Oncology Congress 2023
20 Nov 2023
EORTC Quality of Life measures integrated in CDISC
7 Nov 2023
EORTC and Immunocore are collaborating to launch the ATOM clinical trial of tebentafusp in Adjuvant Uveal Melanoma
31 Oct 2023
Treatment with decitabine resulted in a similar survival and fewer adverse events compared with conventional chemotherapy in older fit patients with acute myeloid leukaemia
20 Oct 2023
New results and forthcoming EORTC trials in rare cancers, lung, head and neck, and breast carcinomas presented at ESMO 2023